These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18493251)

  • 21. Regional Differences in Serotonin Transporter Occupancy by Escitalopram: An [
    Kim E; Howes OD; Kim BH; Chon MW; Seo S; Turkheimer FE; Lee JS; Lee YS; Kwon JS
    Clin Pharmacokinet; 2017 Apr; 56(4):371-381. PubMed ID: 27557550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-HT1B receptor modulation of the serotonin transporter in vivo: studies using KO mice.
    Montañez S; Munn JL; Owens WA; Horton RE; Daws LC
    Neurochem Int; 2014 Jul; 73():127-31. PubMed ID: 24246466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats.
    Mochizuki D; Tsujita R; Yamada S; Kawasaki K; Otsuka Y; Hashimoto S; Hattori T; Kitamura Y; Miki N
    Psychopharmacology (Berl); 2002 Jul; 162(3):323-32. PubMed ID: 12122491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measuring SSRI occupancy of SERT using the novel tracer [123I]ADAM: a SPECT validation study.
    Erlandsson K; Sivananthan T; Lui D; Spezzi A; Townsend CE; Mu S; Lucas R; Warrington S; Ell PJ
    Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1329-36. PubMed ID: 16133377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tuning the activity of known drugs via the introduction of halogen atoms, a case study of SERT ligands - Fluoxetine and fluvoxamine.
    Staroń J; Pietruś W; Bugno R; Kurczab R; Satała G; Warszycki D; Lenda T; Wantuch A; Hogendorf AS; Hogendorf A; Duszyńska B; Bojarski AJ
    Eur J Med Chem; 2021 Aug; 220():113533. PubMed ID: 34049262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study.
    Klein N; Sacher J; Geiss-Granadia T; Mossaheb N; Attarbaschi T; Lanzenberger R; Spindelegger C; Holik A; Asenbaum S; Dudczak R; Tauscher J; Kasper S
    Psychopharmacology (Berl); 2007 Apr; 191(2):333-9. PubMed ID: 17235610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic dopamine increase in the rat prefrontal cortex with the combination of quetiapine and fluvoxamine.
    Denys D; Klompmakers AA; Westenberg HG
    Psychopharmacology (Berl); 2004 Nov; 176(2):195-203. PubMed ID: 15138756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of enhanced effect of antipsychotics combined with fluvoxamine on acetylcholine release in rat prefrontal cortex.
    Ago Y; Sato M; Nakamura S; Baba A; Matsuda T
    J Pharmacol Sci; 2006 Dec; 102(4):419-22. PubMed ID: 17130670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antidepressants targeting the serotonin reuptake transporter act via a competitive mechanism.
    Apparsundaram S; Stockdale DJ; Henningsen RA; Milla ME; Martin RS
    J Pharmacol Exp Ther; 2008 Dec; 327(3):982-90. PubMed ID: 18801947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preclinical to clinical translation of CNS transporter occupancy of TD-9855, a novel norepinephrine and serotonin reuptake inhibitor.
    Smith JA; Bourdet DL; Daniels OT; Ding YS; Gallezot JD; Henry S; Kim KH; Kshirsagar S; Martin WJ; Obedencio GP; Stangeland E; Tsuruda PR; Williams W; Carson RE; Patil ST
    Int J Neuropsychopharmacol; 2014 Dec; 18(2):. PubMed ID: 25522383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time course of in vivo 5-HTT transporter occupancy by fluvoxamine.
    Takano A; Suhara T; Ichimiya T; Yasuno F; Suzuki K
    J Clin Psychopharmacol; 2006 Apr; 26(2):188-91. PubMed ID: 16633150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic administration of the SSRI fluvoxamine markedly and selectively reduces the sensitivity of cortical serotonergic neurons to footshock stress.
    Dazzi L; Seu E; Cherchi G; Biggio G
    Eur Neuropsychopharmacol; 2005 May; 15(3):283-90. PubMed ID: 15820417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular serotonin in the prefrontal cortex is limited through terminal 5-HT(1B) autoreceptors: a microdialysis study in knockout mice.
    de Groote L; Olivier B; Westenberg HG
    Psychopharmacology (Berl); 2002 Aug; 162(4):419-24. PubMed ID: 12172696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential inhibitory effects of drugs acting at the noradrenaline and 5-hydroxytryptamine transporters in rat and human neocortical synaptosomes.
    Mantovani M; Dooley DJ; Weyerbrock A; Jackisch R; Feuerstein TJ
    Br J Pharmacol; 2009 Dec; 158(7):1848-56. PubMed ID: 19912224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level.
    Benmansour S; Cecchi M; Morilak DA; Gerhardt GA; Javors MA; Gould GG; Frazer A
    J Neurosci; 1999 Dec; 19(23):10494-501. PubMed ID: 10575045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo effects of the simultaneous blockade of serotonin and norepinephrine transporters on serotonergic function. Microdialysis studies.
    Bel N; Artigas F
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1064-72. PubMed ID: 8819487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurotransmitter transporter occupancy following administration of centanafadine sustained-release tablets: A phase 1 study in healthy male adults.
    Matuskey D; Gallezot JD; Nabulsi N; Henry S; Torres K; Dias M; Angarita GA; Huang Y; Shoaf SE; Carson RE; Mehrotra S
    J Psychopharmacol; 2023 Feb; 37(2):164-171. PubMed ID: 36515395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram.
    Klein N; Sacher J; Geiss-Granadia T; Attarbaschi T; Mossaheb N; Lanzenberger R; Pötzi C; Holik A; Spindelegger C; Asenbaum S; Dudczak R; Tauscher J; Kasper S
    Psychopharmacology (Berl); 2006 Oct; 188(3):263-72. PubMed ID: 16955282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of serotonergic function in rat brain by tryptophan depletion: effects in control and fluvoxamine-treated rats.
    Bel N; Artigas F
    J Neurochem; 1996 Aug; 67(2):669-76. PubMed ID: 8764594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].
    Mnie-Filali O; El Mansari M; Scarna H; Zimmer L; Sánchez C; Haddjeri N
    Encephale; 2007 Dec; 33(6):965-72. PubMed ID: 18789789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.